Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics

Evren, Cuneyt; Karabulut, Vahap

doi:10.14744/DAJPNS.2019.00013

Editorial

Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics

Cuneyt Evren ¹

, Vahap Karabulut ¹

¹Bakirkoy Training and Research Hospital for Psychiatry Neurology and Neurosurgery, Research, Treatment and Training Center for Alcohol and Substance Dependence (AMATEM), Istanbul - Turkey

Dusunen Adam J Psychiatr Neurol Sci 2019; 32(2): 81-86 DOI: 10.14744/DAJPNS.2019.00013

Full Text PDF

Evren C, Karabulut V. Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics. Dusunen Adam J Psychiatr Neurol Sci. 2019 ;32(2):81-86. doi: 10.14744/DAJPNS.2019.00013.

Evren C, Karabulut V. Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics. Dusunen Adam J Psychiatr Neurol Sci. 2019;32(2):81-86. doi: 10.14744/DAJPNS.2019.00013

Evren, C., & Karabulut, V. (2019). Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics. Dusunen Adam Journal of Psychiatry and Neurological Sciences, 32(2), 81-86. https://doi.org/10.14744/DAJPNS.2019.00013

Evren, C., and V. Karabulut. "Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics." Dusunen Adam Journal of Psychiatry and Neurological Sciences, vol. 32, no. 2, 2019, pp. 81-86. https://doi.org/10.14744/DAJPNS.2019.00013.

Evren, C., V. Karabulut. 2019. "Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics." Dusunen Adam Journal of Psychiatry and Neurological Sciences 32, no. 2: 81-86. https://doi.org/10.14744/DAJPNS.2019.00013.

Journal Display Format:

Authors: Cuneyt Evren, Vahap Karabulut
Article Title: Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics
Journal Name: Dusunen Adam Journal of Psychiatry and Neurological Sciences
Year: 2019
Volume: 32
Issue: 2
Pages: 81 - 86
DOI: 10.14744/DAJPNS.2019.00013

RIS BibTeX EndNote Medlars